153 related articles for article (PubMed ID: 19374865)
1. PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells.
Rival Y; Puech L; Taillandier T; Benéteau N; Rouquette A; Lestienne F; Dupont-Passelaigue E; Le Roy I; Patoiseau JF; Junquéro D
Eur J Pharmacol; 2009 Mar; 606(1-3):121-9. PubMed ID: 19374865
[TBL] [Abstract][Full Text] [Related]
2. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice.
Narita M; Shimamura M; Imai S; Kubota C; Yajima Y; Takagi T; Shiokawa M; Inoue T; Suzuki M; Suzuki T
Neuroscience; 2008 Mar; 152(2):477-86. PubMed ID: 18262365
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of COXs and 5-LOX and activation of PPARs by Australian Clematis species (Ranunculaceae).
Li RW; Lin GD; Leach DN; Waterman PG; Myers SP
J Ethnopharmacol; 2006 Mar; 104(1-2):138-43. PubMed ID: 16207522
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta.
Chen YL; Hu CS; Lin FY; Chen YH; Sheu LM; Ku HH; Shiao MS; Chen JW; Lin SJ
J Cell Biochem; 2006 Jun; 98(3):618-31. PubMed ID: 16440326
[TBL] [Abstract][Full Text] [Related]
8. The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.
Delage B; Rullier A; Capdepont M; Rullier E; Cassand P
Nutr J; 2007 Sep; 6():20. PubMed ID: 17767717
[TBL] [Abstract][Full Text] [Related]
9. Trifunctional inhibition of COX-2 by extracts of Lonicera japonica: direct inhibition, transcriptional and post-transcriptional down regulation.
Xu Y; Oliverson BG; Simmons DL
J Ethnopharmacol; 2007 May; 111(3):667-70. PubMed ID: 17314019
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
12. Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation.
Foudi N; Louedec L; Cachina T; Brink C; Norel X
Cardiovasc Res; 2009 Feb; 81(2):269-77. PubMed ID: 18952694
[TBL] [Abstract][Full Text] [Related]
13. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
14. The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning.
Lafuente N; Matesanz N; Azcutia V; Romacho T; Nevado J; Rodríguez-Mañas L; Moncada S; Peiró C; Sánchez-Ferrer CF
J Hypertens; 2008 Mar; 26(3):478-85. PubMed ID: 18300858
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells.
Lemire JM; Chan CK; Bressler S; Miller J; LeBaron RG; Wight TN
J Cell Biochem; 2007 Jun; 101(3):753-66. PubMed ID: 17226775
[TBL] [Abstract][Full Text] [Related]
16. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
[TBL] [Abstract][Full Text] [Related]
18. Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine, and green tea phenolics in human aortic smooth muscle cells.
Ivanov V; Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
J Cardiovasc Pharmacol; 2007 Mar; 49(3):140-5. PubMed ID: 17414225
[TBL] [Abstract][Full Text] [Related]
19. Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells.
Yin BL; Hao H; Wang YY; Jiang YJ; Xue S
Inflamm Res; 2009 Feb; 58(2):67-73. PubMed ID: 19184356
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
Denning GM; Stoll LL
Pediatr Pulmonol; 2006 Jan; 41(1):23-34. PubMed ID: 16267824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
